In a significant milestone for neurovascular innovation, EndoStream Medical has been acquired by Kaneka Corporation (TYO: 4118), a global leader in healthcare solutions. This acquisition represents a company value of $100 million, with the potential for significant growth based on future sales.
Founded in 2015, EndoStream developed the Nautilus™ implant, a revolutionary solution for treating brain aneurysms. Since its introduction, the Nautilus™ implant has been used successfully in hundreds of procedures worldwide, providing a groundbreaking and life-saving approach. The company is headed by Danel Mayer, CEO; and Alon May, CTO.
Peregrine Ventures has proudly supported EndoStream since 2020, serving as the sole venture capital investor, alongside leading U.S. neurosurgeons.
The collaboration with Kaneka Corporation marks an exciting new chapter for EndoStream. Kaneka’s advanced manufacturing capabilities, combined with EndoStream’s innovative technology, will enable the Nautilus™ implant to reach even more patients while driving further innovation in cerebrovascular care.
